Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells

Molecular and Cellular Neuroscience

Volumn 39, Issue 4, 2008, Pages 549-568

  Sbai, Oualid ^a   Ferhat, Lotfi ^a   Bernard, Anne ^a   Gueye, Yatma ^a   Ould Yahoui, Adlane ^a   Thiolloy, Sophie ^a   Charrat, Eliane ^a   Charton, Gérard ^a   Tremblay, Evelyne ^a   Risso, Jean Jacques ^b   Chauvin, Jean Paul ^c   Arsanto, Jean Pierre ^c   Rivera, Santiago ^a   Khrestchatisky, Michel ^a  

^a Mediterranée University   (France)

^b IMNSSA   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; GELATINASE A; GELATINASE B; GREEN FLUORESCENT PROTEIN; KINESIN; MOLECULAR MOTOR; MYOSIN VA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL SECRETION; CELL VACUOLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOLOGY; DENDRITE; DENDRITIC SPINE; ELECTRON MICROSCOPY; EMBRYO; ENZYME ACTIVITY; GENETIC TRANSFECTION; GOLGI COMPLEX; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; LONG TERM POTENTIATION; MICROFILAMENT; MICROTUBULE; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NEUROBLASTOMA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PYRAMIDAL NERVE CELL; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CYTOPLASMIC VESICLES; CYTOSKELETON; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MOLECULAR MOTOR PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 56249114089     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.08.004     Document Type: Article

References (76)

1. Baas P.W. Microtubules and neuronal polarity: lessons from mitosis. Neuron 22 (1999) 23-31
2. Ben-Hur T., Ben-Yosef Y., Mizrachi-Kol R., Ben-Menachem O., and Miller A. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells. J. Neuroimmunol. 175 (2006) 12-18
3. Bilousova T.V., Rusakov D.A., Ethell D.W., and Ethell I.M. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J. Neurochem. 97 (2006) 44-56
4. Bonnon C., Goutebroze L., Denisenko-Nehrbass N., Girault J.-A., and Faivre-Sarrailh C. The paranodal complex of F3/contactin and caspr/paranodin traffics to the cell surface via a non-conventional pathway. J. Biol. Chem. 278 (2003) 48339-48347
5. Bozdagi O., Nagy V., Kwei K.T., and Huntley G.W. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J. Neurophysiol. 98 (2007) 334-344
6. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42 (1995) 674-683
7. Bridgman P.C., and Elkin L.L. Axonal myosins. J. Neurocytol. 29 (2000) 831-841
8. Bridgman P.C. Myosin-dependent transport in neurons. J. Neurobiol. 58 (2004) 164-174
9. Burkhardt J.K., Echeverri C.J., Nilsson T., and Vallee R.B. Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J. Cell Biol. 139 (1997) 469-484
10. Chaillan F.A., Rivera S., Marchetti E., Jourquin J., Werb Z., Soloway P.D., Khrestchatisky M., and Roman F.S. Involvement of tissue inhibitor of metalloproteinase-1 in learning and memory in mice. Beh. Brain Res. 173 (2006) 191-198
11. Chambaut-Guerin A.-M., Herigault S., Rouet-Benzineb P., Rouher C., and Lafuma C. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells. Relevance to Neuronal Differentiation. J. Neurochem. 74 (2000) 508-517
12. Chintala S.K., Sawaya R., Aggarwal B.B., Majumder S., Giri D.K., Kyritsis A.P., Gokaslan Z.L., and Rao J.S. Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J. Biol. Chem. 273 (1998) 13545-13551
13. Crocker S.J., Whitmire J.K., Frausto R.F., Chertboonmuang P., Soloway P.D., Whitton J.L., and Campbell I.L. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am. J. Pathol. 169 (2006) 2104-2116
14. DePina A.S., and Langford G.M. Vesicle transport: the role of actin filaments and myosin motors. Micros. Res. Techniq. 47 (1999) 93-106
15. Deryugina E.I., Ratnikov B.I., Yu Q., Baciu P.C., Rozanov D.V., and Strongin A.Y. Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in furin-negative colon carcinoma LoVo cells. Traffic 5 (2004) 627-641
16. Dolo V., Ginestra A., Ghersi G., Nagase H., and Vittorelli M.L. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J. Submicrosc. Cyto. Pathol. 26 (1994) 173-180
17. Dolo V., Ginestra A., Cassara D., Violini S., Lucania G., Torrisi M.R., Nagase H., Canevari S., Pavan A., and Vittorelli M.L. Selective localization of matrix metalloproteinase 9, β1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 58 (1998) 4468-4474
18. Dzwonek J., Rylski M., and Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567 (2004) 129-135
19. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
20. Ethell I.M., and Ethell D.W. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J. Neurosci. Res. 85 (2007) 2813-2823
21. Ferhat L., Rami G., Medina I., Ben-Ari Y., and Represa A. Process formation results from the imbalance between motor-mediated forces. J. Cell Sci. 114 (2001) 3899-3904
22. Fujiwara T., Oda K., Yokota S., Takatsuki A., and Ikehara Y. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263 (1988) 18545-18552
23. Gardner J., and Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74 (2003) 801-806
24. Ginestra A., Monea S., Seghezzi G., Dolo V., Nagase H., Mignatti P., and Vittorelli M.L. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem. 272 (1997) 17216-17222
25. Giraudon P., Buart S., Bernard A., and Belin M.F. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes. Mol. Psychiatry 2 (1997) 107-110
26. Goldberg M., Septier D., Bourd K., Hall R., George A., Goldberg H., and Menashi S. Immunohistochemical localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the forming rat incisor. Connect. Tissue Res. 44 (2003) 143-153
27. Graves L.E., Ariztia E.V., Navari J.R., Matzel H.J., Stack M.S., and Fishman D.A. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 64 (2004) 7045-7049
28. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., and Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297 (2002) 1186-1190
29. Harris J.R., and Horne R.W. Negative staining. In: Harris J.R. (Ed). Electron Microscopy in Biology (1991), Oxford University Press, Oxford
30. Hehnly H., and Stamnes M. Regulating cytoskeleton-based vesicle motility. FEBS Lett. 581 (2007) 2112-2118
31. Ho W.-T., Exton J.H., and Williger B.-T. Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells. FEBS Lett. 537 (2003) 91-95
32. Hsu J.-Y.C., McKeon R., Goussev S., Werb Z., Lee J.-U., Trivedi A., and Noble-Haeusslein L.J. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J. Neurosci. 26 (2006) 9841-9850
33. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardher T., Khrestchatisky M., and Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 18 (2003) 1507-1517
34. Jourquin J., Tremblay E., Bernard A., Charton G., Chaillan F.A., Marchetti E., Roman F.S., Soloway P.D., Dive V., Yiotakis A., Khrestchatisky M., and Rivera S. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur. J. Neurosci. 22 (2005) 2569-2578
35. Keller S., Sanderson M.P., Stoeck A., and Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol. Lett. 107 (2006) 102-108
36. Komano H., Sudoh S., Kawamura Y., Wang R., and Yanagisawa K. Implications of presenilin 1 mutations in Alzheimer's disease. Mech. Ageing Develop. 107 (1999) 281-298
37. Konopacki F.A., Rylski M., Wilczek E., Amborska R., Detka D., Kaczmarek L., and Wilczynski G.M. Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 150 (2007) 31-39
38. Langford G. Actin- and microtubule-dependent organelle motors: interrelationships between the two motility systems. Curr. Opin. Cell Biol. 7 (1995) 82-88
39. Langford G.M. Myosin-V, a versatile motor for short-range vesicle transport. Traffic 3 (2002) 859-865
40. Le N.T., Xue M., Castelnoble L., and Jackson C. The dual personalities of matrix metalloproteinases in inflammation. Front. Biosc. 12 (2007) 1475-1487
41. Levy J., and Holzbaur E. Cytoplasmic dynein/dynactin function and dysfunction in motor neurons. Int. J. Dev. Neurosci. 24 (2006) 103-111
42. Lopez-Otin C., and Matrisian L.M. Emerging roles of proteases in tumour suppression. Nat. Rev. Cancer 7 (2007) 800-808
43. Meighan P.C., Meighan S.E., Davis C.J., Wright J.W., and Harding J.W. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of Schaffer collateral/CA1 synapses. J. Neurochem. 102 (2007) 2085-2096
44. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., Wright J.W., and Harding J.W. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J. Neurochem. 96 (2006) 1227-1241
45. Muir E.M., Adcock K.H., Morgenstern D.A., Clayton R., von Stillfried N., Rhodes K., Ellis C., Fawcett J.W., and Rogers J.H. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Mol. Brain Res. 100 (2002) 103-117
46. Muresan V. One axon, many kinesins: what's the logic?. J. Neurocytol. 29 (2000) 799-818
47. Nagy V., Bozdagi O., and Huntley G.W. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learn. Mem. 14 (2007) 655-664
48. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., and Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 26 (2006) 1923-1934
49. Ogier C., Creidy R., Boucraut J., Soloway P., Khrestchatisky M., and Rivera S. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. BMC Neurosci. 6 (2005) 68
50. Ogier C., Bernard A., Chollet A.N., Le Diguardher T., Hanessian S., Charton G., Khrestchatisky M., and Rivera S. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 54 (2006) 272-284
51. Okulski P., Jay T.M., Jaworski J., Duniec K., Dzwonek J., Konopacki F.A., Wilczynski G.M., Sanchez-Capelo A., Mallet J., and Kaczmarek L. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol. Psychiatry 62 (2007) 359-362
52. Oliver G.W., Leferson J.D., Stetler-Stevenson W.G., and Kleiner D.E. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem. 244 (1997) 161-166
53. Pagenstecher A., Stalder A.K., Kincaid C.L., Shapiro S.D., and Campbell I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152 (1998) 729-741
54. Papp A.M., Nyilas R., Szepesi Z., Lorincz M.L., Takacs E., Abraham I., Szilagyi N., Toth J., Medveczky P., Szilagyi L., and Juhasz G. Visible light induces matrix metalloproteinase-9 expression in rat eye. J. Neurochem. 103 (2007) 2224-2233
55. Rahat M.A., Marom B., Bitterman H., Weiss-Cerem L., Kinarty A., and Lahat N. Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J. Leukoc. Biol. 79 (2006) 706-718
56. Rivera S., Tremblay E., Timsit S., Canals O., Ben-Ari Y., and Khrestchatisky M. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J. Neurosci. 17 (1997) 4223-4235
57. Rivera S., and Khrestchatisky M. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuronal plasticity and pathology. In: Baudry M., Thomsom R.F., and Davis J.L. (Eds). Advances in Synaptic Plasticity (1999), The MIT Press, Cambridge, MA 53-86
58. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A.W., Miller K., Gearing A.J.H., Kaczmarek L., and Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur. J. Neurosci. 15 (2002) 19-32
59. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
60. Sanka K., Maddala R., Epstein D.L., and Rao P.V. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 48 (2007) 2105-2114
61. Schnaeker E.-M., Ossig R., Ludwig T., Dreier R., Oberleithner H., Wilhelmi M., and Schneider S.W. Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res. 64 (2004) 8924-8931
62. Shea T.B., Fischer I., and Sapirstein V.S. Effect of retinoic acid on growth and morphological differentiation of mouse NB2a neuroblastoma cells in culture. Brain Res. 353 (1985) 307-314
63. Sheetz M.P. Motor and cargo interactions. Eur. J. Biochem. 262 (1999) 19-25
64. Schnapp B.J., and Reese T.S. Dynein is the motor for retrograde axonal transport of organelles. PNAS 86 (1989) 1548-1552
65. Sugiura Y., Shimada H., Seeger R.C., Laug W.E., and DeClerck Y.A. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58 (1998) 2209-2216
66. Szklarczyk A., Lapinska J., Rylski M., McKay R.D.G., and Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22 (2002) 920-930
67. Tan H.K., Heywood D., Ralph G.S., Bienemann A., Baker A.H., and Uney J.B. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol. Cel. Neurosci. 22 (2003) 98-106
68. Taraboletti G., Sonzogni L., Vergani V., Hosseini G., Ceruti R., Ghilardi C., Bastone A., Toschi E., Borsotti P., Scanziani E., Giavazzi R., Pepper M.S., Stetler-Stevenson W.G., and Bani M.R. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells. Exp. Cell Res. 258 (2000) 384-394
69. Taraboletti G., D'Ascenzo S., Borsotti P., Giavazzi R., Pavan A., and Dolo A. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 160 (2002) 673-680
70. Taraboletti G., D'Ascenzo S., Giusti I., Marchetti D., Borsotti P., Millimaggi D., Giavazzi R., Pavan A., and Dolo A. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8 (2006) 96-103
71. Vaillant C., Didier-Bazes M., Hutter A., Belin M.-F., and Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J. Neurosci. 19 (1999) 4994-5004
72. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., Wawrzyniak M., Malinowska M., Okulski P., Kolodziej L.R., Konopka W., Duniec K., Mioduszewska B., Nikolaev E., Walczak A., Owczarek D., Gorecki D.C., Zuschratter W., Ottersen O.P., and Kaczmarek L. Important role of matrix metalloproteinase 9 in epileptogenesis. J. Cell Biol. 180 (2008) 1021-1035
73. Yong W.V., Forsyth P.A., Bell R., Krekoski C.A., and Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21 (1998) 75-80
74. Zhao B.-Q., Tejima E., and Lo E.H. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 38 (2007) 748-752
75. Zucker S., Wieman J.M., Lysik R.M., Wilkie D.P., Ramamurthy N., and Lane B. Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles. Biochim. Biophys. Acta 924 (1987) 225-237
76. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., and Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18 (1998) 5203-5211